Skip to main content
Log in

Platelet-rich plasma alleviates knee arthritis in rats by inhibiting p65

  • Full Length Paper
  • Published:
Cell and Tissue Banking Aims and scope Submit manuscript

Abstract

Knee osteoarthritis (KOA) is a chronic joint disease characterized by the degeneration of articular cartilage. In this study, we explored the potential therapeutic effects of platelet-rich plasma (PRP) and identified molecular targets for treating KOA. A rat model of KOA was established via the Hulth method and primary knee joint chondrocytes were isolated to evaluate the effects of PRP and shRNA targeting p65 (sh-p65). ELISA was used to detect inflammatory factors, including IL-6, IL-1β, and TNF-α. HE staining, Safranin O/Fast Green staining and Masson staining were performed to evaluate the morphology of articular cartilage, followed by detection of p65, COL2A1, ACAN, MMP13, and ADAMTS5 expression. The proliferation and apoptosis of primary knee chondrocytes were detected by the CCK-8 assay and TUNEL staining, respectively. Treatment with either PRP or sh-p65 decreased IL-6, IL-1β, and TNF-α levels in the peripheral blood of KOA rats and chondrocyte culture supernatants, increased COL2A1 and ACAN levels, and decreased MMP13 and ADAMTS5 expression. Furthermore, administration of PRP or sh-p65 exerted protective effects on articular cartilage, enhanced the vitality of knee joint chondrocytes, and inhibited apoptosis. Collectively, PRP inhibited inflammation, promoted chondrocyte proliferation and cartilage matrix secretion, and induced cartilage regeneration by suppressing p65 expression; these effects allow PRP to alleviate KOA progression. P65-based targeted therapy administered in combination with PRP might be a promising strategy for treating KOA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The datasets generated and analyzed during the current study are not publicly available because some data will be used for future research. However, the datasets are available from the corresponding author upon reasonable request.

References

  • Andia I, Abate M (2018) Platelet-rich plasma: combinational treatment modalities for musculoskeletal conditions. Front Med 12:139–152

    Article  PubMed  Google Scholar 

  • Armiento AR, Stoddart MJ, Alini M, Eglin D (2018) Biomaterials for articular cartilage tissue engineering: learning from biology. Acta Biomater 65:1–20

    Article  CAS  PubMed  Google Scholar 

  • Asjid R, Faisal T, Qamar K, Malik S, Umbreen F, Fatima M (2019) Effect of platelet-rich plasma on mankin scoring in chemically-induced animal model of osteoarthritis. J Coll Physicians Surg Pak 29:1067–1071

    Article  PubMed  Google Scholar 

  • Charlesworth J, Fitzpatrick J, Perera NKP, Orchard J (2019) Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee. BMC Musculoskelet Disord 20:151

    Article  PubMed  PubMed Central  Google Scholar 

  • Chiou CS, Wu CM, Dubey NK et al (2018) Mechanistic insight into hyaluronic acid and platelet-rich plasma-mediated anti-inflammatory and anti-apoptotic activities in osteoarthritic mice. Aging (albany NY) 10:4152–4165

    Article  CAS  PubMed  Google Scholar 

  • Dai J, Zhou S, Ge Q et al (2018) Bi-directional regulation of cartilage metabolism by inhibiting BET proteins-analysis of the effect of I-BET151 on human chondrocytes and murine joints. J Orthop Surg Res 13:118

    Article  PubMed  PubMed Central  Google Scholar 

  • Delanois RE, Etcheson JI, Sodhi N et al (2019) Biologic therapies for the treatment of knee osteoarthritis. J Arthroplasty 34:801–813

    Article  PubMed  Google Scholar 

  • Fadadu PP, Mazzola AJ, Hunter CW, Davis TT (2019) Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: a call for PRP standardization. Reg Anesth Pain Med 44:652–659

    Article  Google Scholar 

  • Gato-Calvo L, Magalhaes J, Ruiz-Romero C, Blanco FJ, Burguera EF (2019) Platelet-rich plasma in osteoarthritis treatment: review of current evidence. Ther Adv Chronic Dis 10:2040622319825567

    Article  PubMed  PubMed Central  Google Scholar 

  • Geyer M, Schonfeld C (2018) Novel insights into the pathogenesis of osteoarthritis. Curr Rheumatol Rev 14:98–107

    Article  CAS  PubMed  Google Scholar 

  • Giridharan S, Srinivasan M (2018) Mechanisms of NF-kappaB p65 and strategies for therapeutic manipulation. J Inflamm Res 11:407–419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Griffin TM, Scanzello CR (2019) Innate inflammation and synovial macrophages in osteoarthritis pathophysiology. Clin Exp Rheumatol 37(Suppl 120):57–63

    PubMed  PubMed Central  Google Scholar 

  • Grol MW, Lee BH (2018) Gene therapy for repair and regeneration of bone and cartilage. Curr Opin Pharmacol 40:59–66

    Article  CAS  PubMed  Google Scholar 

  • Guilak F, Nims RJ, Dicks A, Wu CL, Meulenbelt I (2018) Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol 71–72:40–50

    Article  PubMed  PubMed Central  Google Scholar 

  • Ha CW, Park YB, Jang JW, Kim M, Kim JA, Park YG (2019) Variability of the composition of growth factors and cytokines in platelet-rich plasma from the knee with osteoarthritis. Arthroscopy 35:2878–2884

    Article  PubMed  Google Scholar 

  • Han PF, Wei L, Duan ZQ et al (2018) Contribution of IL-1beta, 6 and TNF-alpha to the form of post-traumatic osteoarthritis induced by “idealized” anterior cruciate ligament reconstruction in a porcine model. Int Immunopharmacol 65:212–220

    Article  CAS  PubMed  Google Scholar 

  • Jung YK, Park HR, Cho HJ et al (2019) Degrading products of chondroitin sulfate can induce hypertrophy-like changes and MMP-13/ADAMTS5 production in chondrocytes. Sci Rep 9:15846

    Article  PubMed  PubMed Central  Google Scholar 

  • Kiraz Y, Adan A, Kartal Yandim M, Baran Y (2016) Major apoptotic mechanisms and genes involved in apoptosis. Tumour Biol 37:8471–8486

    Article  CAS  PubMed  Google Scholar 

  • Le ADK, Enweze L, DeBaun MR, Dragoo JL (2019) Platelet-rich plasma. Clin Sports Med 38:17–44

    Article  PubMed  Google Scholar 

  • Lei CQ, Wu X, Zhong X, Jiang L, Zhong B, Shu HB (2019) USP19 inhibits TNF-alpha- and IL-1beta-triggered NF-kappaB activation by deubiquitinating TAK1. J Immunol 203:259–268

    Article  CAS  PubMed  Google Scholar 

  • Li L, Yu F, Zheng L et al (2019) Natural hydrogels for cartilage regeneration: modification, preparation and application. J Orthop Translat 17:26–41

    Article  PubMed  Google Scholar 

  • Liu J, Cao L, Gao X et al (2018) Ghrelin prevents articular cartilage matrix destruction in human chondrocytes. Biomed Pharmacother 98:651–655

    Article  CAS  PubMed  Google Scholar 

  • Liu S, Jia H, Hou S et al (2018) Recombinant Mtb9.8 of Mycobacterium bovis stimulates TNF-alpha and IL-1beta secretion by RAW264.7 macrophages through activation of NF-kappaB pathway via TLR2. Sci Rep 8:1928

    Article  PubMed  PubMed Central  Google Scholar 

  • Liu Y, Yang J, Luo Z et al (2019) Development of an injectable thiolated icariin functionalized collagen/hyaluronic hydrogel to promote cartilage formation in vitro and in vivo. J Mater Chem B 7:2845–2854

    Article  CAS  PubMed  Google Scholar 

  • Mitchell JP, Carmody RJ (2018) NF-kappaB and the transcriptional control of inflammation. Int Rev Cell Mol Biol 335:41–84

    Article  CAS  PubMed  Google Scholar 

  • Peltzer N, Walczak H (2019) Cell death and Inflammation - a vital but dangerous liaison. Trends Immunol 40:387–402

    Article  CAS  PubMed  Google Scholar 

  • Rahimzadeh P, Imani F, Faiz SHR, Entezary SR, Zamanabadi MN, Alebouyeh MR (2018) The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clin Interv Aging 13:73–79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ (2016) Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med 44:792–800

    Article  PubMed  Google Scholar 

  • Samadi P, Sheykhhasan M, Khoshinani HM (2019) The use of platelet-rich plasma in aesthetic and regenerative medicine: a comprehensive review. Aesthetic Plast Surg 43:803–814

    Article  PubMed  Google Scholar 

  • Sanchez M, Anitua E, Delgado D et al (2016) A new strategy to tackle severe knee osteoarthritis: combination of intra-articular and intraosseous injections of platelet rich plasma. Expert Opin Biol Ther 16:627–643

    Article  CAS  PubMed  Google Scholar 

  • Southworth TM, Naveen NB, Tauro TM, Leong NL, Cole BJ (2019) The use of platelet-rich plasma in symptomatic knee osteoarthritis. J Knee Surg 32:37–45

    Article  PubMed  Google Scholar 

  • Tang X, Wang S, Zhan S et al (2016) The prevalence of symptomatic knee osteoarthritis in China: results from the china health and retirement longitudinal study. Arthritis Rheumatol 68:648–653

    Article  PubMed  Google Scholar 

  • Tavassoli M, Janmohammadi N, Hosseini A, Khafri S, Esmaeilnejad-Ganji SM (2019) Single- and double-dose of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: a randomized controlled trial. World J Orthop 10:310–326

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang T, He C (2018) Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev 44:38–50

    Article  PubMed  Google Scholar 

  • Wei ZJ, Liu J, Qin J (2017) miR-138 suppressed the progression of osteoarthritis mainly through targeting p65. Eur Rev Med Pharmacol Sci 21:2177–2184

    PubMed  Google Scholar 

  • Yin X, Wang JQ, Yan SY (2017) Reduced miR26a and miR26b expression contributes to the pathogenesis of osteoarthritis via the promotion of p65 translocation. Mol Med Rep 15:551–558

    Article  CAS  PubMed  Google Scholar 

  • Zhang HF, Wang CG, Li H, Huang YT, Li ZJ (2018) Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis. Drug Des Devel Ther 12:445–453

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

FZ and XFY designed the experiments. FZ, XJJ, ZRW and YYZ performed the experiments. FZ created and finalized the manuscript, table and figure. XFY critically revised and expanded sections of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xinfeng Yan.

Ethics declarations

Conflict of interest

All authors declare having no conflicts of interest.

Ethical approval and consent to participate

The experiments obtained approval form the Ethics Committee for Animal Experiments of Shandong University and was compliant with ARRIVE guidelines. All methods were performed in accordance with the relevant guidelines and regulations from the Ethics Committee for Animal Experiments of Shandong University [SDAL (2020)0063-2].

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplement Figure 1, a quantitative analysis plot on western blot (DOCX 8779 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhuo, F., Jia, X., Wang, Z. et al. Platelet-rich plasma alleviates knee arthritis in rats by inhibiting p65. Cell Tissue Bank (2023). https://doi.org/10.1007/s10561-023-10102-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10561-023-10102-3

Keywords

Navigation